Low cardiovascular risk and poor quality of life associated with tobacco use and skin infections in adult atopic dermatitis: result of a French multicenter study

Atopic Dermatitis

Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a randomized, placebo-controlled clinical trial

Br J Dermatol.

Tsianakas A, Luger TA, Radin A

doi: 10.1111/bjd.15905.

Atopic Dermatitis

Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis

JAMA Dermatol.

Asgari MM, Tsai AL, Avalos L, Sokil M, Quesenberry CP Jr

doi: 10.1001/jamadermatol.

Atopic Dermatitis

Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study

J Investig Allergol Clin Immunol.

Nettis E, Ferrucci SM, Ortoncelli M, Pellacani G, Foti C, Di Leo E, Patruno C, Rongioletti F, Argenziano G, Macchia L, Tavecchio S, Napolitano M, Ribero S, Bonzano L, Romita P, Di Bona D, Nisticò SP, Piras V, Calabrese G, Detoraki C, Carbonara M, Fabbrocini G

doi: 10.18176/jiaci.0641.

Atopic Dermatitis

Risk of systemic infections in adults with atopic dermatitis: a nationwide cohort study

J Am Acad Dermatol.

Droitcourt C, Vittrup I, Kerbrat S, Egeberg A, Thyssen JP

doi: 10.1016/j.jaad.2020.07.111.

Atopic Dermatitis

Factors associated with improvement of quality of life among parents of children with atopic dermatitis: one-year prospective cohort study

J Eur Acad Dermatol Venereol.

Maksimovic N, Zaric M, Reljic V, Nikolic M, Gazibara T

doi: 10.1111/jdv.15939.

Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials

J Am Acad Dermatol.

Fleming P, Drucker AM

doi: 10.1016/j.jaad.2017.09.052.

Atopic Dermatitis

Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis

J Am Acad Dermatol.

Thyssen JP, Toft PB, Halling-Overgaard AS, Gislason GH, Skov L, Egeberg A

doi: 10.1016/j.jaad.2017.03.003.

RECOMMENDED

Atopic Dermatitis

Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort

J Am Acad Dermatol.

Faiz S, Giovannelli J, Podevin C, Jachiet M, Bouaziz JD, Reguiai Z, Nosbaum A, Lasek A, Ferrier le Bouedec MC, Du Thanh A, Raison-Peyron N, Tetart F, Duval-Modeste AB, Misery L, Aubin F, Dompmartin A, Morice C, Droitcourt C, Soria A, Arnault JP, Delaunay J, Mahe E, Richard MA, Schoeffler A, Lacour JP, Begon E, Walter-Lepage A, Dillies AS, Rappelle-Duruy S, Barete S, Bellon N, Beneton N, Valois A, Barbarot S, Seneschal J, Staumont-Salle D

doi: 10.1016/j.jaad.2019.02.053.

Melanoma and Skin Cancer

Use of the Skin Cancer Quality of Life Impact Tool (SCQOLIT) - a feasibility study in non-melanoma skin cancer

J Eur Acad Dermatol Venereol.

Wali GN, Gibbons E, Kelly L, Reed JR, Matin RN

doi: 10.1111/jdv.15887.

Related content

Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a randomized, placebo-controlled clinical trial

Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis

Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study

Risk of systemic infections in adults with atopic dermatitis: a nationwide cohort study

Factors associated with improvement of quality of life among parents of children with atopic dermatitis: one-year prospective cohort study

Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials

Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis

Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort

Use of the Skin Cancer Quality of Life Impact Tool (SCQOLIT) - a feasibility study in non-melanoma skin cancer